News

Transforming Clinical Trials: Research Grid's Automation Breakthrough

Transforming Clinical Trials: Research Grid's Automation Breakthrough

Revolutionizing Clinical Trial Feasibility with Research Grid

Research Grid (R.grid) has unveiled an innovative Site Feasibility solution designed to streamline the initiation of clinical trials and broaden access to global patient populations. This powerful new tool leverages real-world data in conjunction with Research Grid's extensive network, which includes over 97,000 communities worldwide.

The Need for Speed in Clinical Trials

In today's fast-paced medical landscape, the speed at which clinical trials can begin is critical. Traditionally, the site selection and activation phases of clinical trials have been plagued by delays, often taking six months or longer. This protracted timeline can hinder the progress of essential research and delay bringing potentially life-saving treatments to market.

Understanding the Complexity of Feasibility

Feasibility in clinical research has often been a bottleneck. Factors such as manual oversight, outdated site data, and varied response rates contribute to these delays. Alarmingly, around 80% of clinical trials miss their enrollment deadlines, with significant portions of sites underperforming in patient recruitment:

  • Many sites fail to recruit even a single patient, while over 30% under-enroll.
  • Delays in recruitment extension timelines result in increased costs for 85% of studies.
  • Sites can spend thousands of hours each year on feasibility processes alone.

Expert Insights from Research Grid

Dr. Amber Hill, the founder and CEO of Research Grid, highlights the crucial role of modern technology in overcoming these challenges. "Site feasibility has long been a major cause of delay and inequity in clinical research. We're showing that with the right AI tech, trials can be safely admin-free. This not only streamlines workflows but also increases the likelihood that essential treatments reach the patients who need them more quickly," she stated.

Features of Research Grid's Site Feasibility Solution

The newly launched Site Feasibility Solution is specifically developed to resolve existing challenges in clinical trials, providing instantaneous insights and enhancing operational efficiencies. Here are some of its standout features:

  • Global Patient Access: Tap into over 96,000 verified communities across 157 countries, tailored to meet specific protocol requirements.
  • Accelerated Planning: Replace traditional manual outreach efforts with AI-powered feasibility reports generated in real-time.
  • Inclusive Design: Proactively identify overlooked regions and sites to ensure diverse participant representation.
  • Enhanced Recruitment Capabilities: Focus recruitment efforts on sites with actual access to eligible patients, rather than simply relying on historical performance.
  • Integrated Workflow: Manage and monitor feasibility activities across global teams efficiently from one cohesive platform.

This new tool is available for use in both a self-service capacity and as a fully managed service, granting research teams the flexibility they need, whether they are working on a single study or managing a global clinical portfolio.

Continuing the Journey Towards Automation

This introduction of the Site Feasibility Solution marks another pivotal step in Research Grid's mission to transform the clinical trial landscape. By replacing outdated, manual processes with intelligent automation, Research Grid is committed to driving efficiencies that facilitate faster, smarter, and more inclusive clinical trials worldwide.

About Research Grid

Research Grid operates as the automation engine for clinical trials, aiming to eliminate delays, errors, and engagement issues that are often linked to legacy practices and systems. Established in 2020 by Dr. Amber Hill, the company is headquartered in London and has successfully raised $8 million in venture funding to date. Research Grid specializes in creating effective solutions for patient and community engagement, as well as clinical trial management.

Frequently Asked Questions

What is Research Grid's new Site Feasibility solution?

It is an advanced automation tool designed to enhance the speed and efficiency of clinical trial startup processes, utilizing real-world data and a vast network of communities.

How does the Site Feasibility tool improve trial efficiency?

By automating processes that traditionally take months, the tool provides instant insights and enhances recruitment efforts, significantly cutting down timelines.

Who founded Research Grid?

Research Grid was founded by Dr. Amber Hill in 2020 to address issues in clinical trial management through intelligent automation.

What are the main benefits of using Research Grid's solution?

It simplifies planning, enhances patient access, ensures inclusivity, and allows for more focused recruitment strategies, improving overall trial efficiency.

Is the Site Feasibility Solution available for all types of clinical trials?

Yes, it is designed to be flexible and can be applied to various trial types and therapeutic areas, catering to different research needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 54

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 115

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 145

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 85

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 188

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 50

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 182

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 109

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading

Top 5 Most Recently Viewed Articles

LLCP Promotions: A Positive Spin or a Prelude to Trouble?

Updated Category News Views 211

Levine Leichtman Capital Partners (LLCP) just gave its Finance and Administration team a shake-up with promotions announced on February 17, 2026. Sure, the firm hails from Los Angeles—where they like to keep things sunny—but these moves might be less about shining futures and more about staving off trouble. Who’s Climbing the LLCP Ladder? Key Players Promoted...

Continue Reading
Understanding Novo Nordisk's Market Sentiment and Trends

Updated Category News Views 187

Novo Nordisk's Current Short Interest Overview Novo Nordisk's short percent of float has decreased substantially, reflecting a 7.89% drop since its last report. The company has disclosed that there are currently 23.58 million shares sold short. This figure corresponds to around 0.7% of all the shares that are available for public trading. Given the trading activity,...

Continue Reading
LG Innotek Launches Innovative Digital Key to Transform Driving

Updated Category News Views 226

Revolutionizing Vehicle Access with Innovative Technology LG Innotek has introduced an exciting new product, the 'Next-generation Digital Key Solution'. This innovative technology connects smartphones to vehicles, allowing users to lock and unlock doors and start engines seamlessly through wireless communication. The digital key’s unique design eliminates the risk of...

Continue Reading
Exciting Opportunities: Auction Details for Office Properties

Updated Category News Views 318

Exciting Opportunities: Auction Details for Office Properties Hilco Real Estate Sales has recently announced an upcoming auction featuring two prominent office buildings designed to capture interest from investors and developers alike. Set in highly visible locations, these properties are prime candidates for a range of investment opportunities. Auction Announcement The...

Continue Reading
Grease Monkey and SpeeDee Oil Change Celebrate Franchise Success

Updated Category News Views 243

Grease Monkey and SpeeDee Oil Change Shine in Franchise Rankings Grease Monkey and SpeeDee Oil Change have recently made headlines after securing their spots in the coveted Franchise Times Top 400 list. This recognition showcases their growth and resilience in the automotive service sector, highlighting the commitment to providing excellent service to their customers. A...

Continue Reading